Stocks · Health care · Surgical & Medical Instruments & Apparatus

NEUROONE MEDICAL TECHNOLOGIES Corp

NMTC Clue Score61
United States Fiscal year ends September CIK 0001500198 Results filed 5 Oct 2026

What the insiders did Net buying

By person

15 insiders · 37 transactions
4.0×

Dave Rosa holds only 4.0 times base salary in stock. $2.17M of shares against $535.43K in salary for 2025.

Salary from the company's own proxy. The shares are what Dave Rosa last reported holding, valued at $2.01, the price Common Stock was last bought or sold at on the open market here, on 27 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
David J. Wambeke
Chief Business Officer
$737.40K (2)
—
+$737.40K
199,999
$402.00K
—
Mark Christianson
Market Development Director
—
$512.34K (24)
−$512.34K
20,692
$41.59K
—
Wade Fredrickson
10% owner
—
$250.00K (1)
−$250.00K
2,113,459
$4.25M
−25.6%
Ronald W. McClurg
Chief Financial Officer
$200.24K (6)
—
+$200.24K
444,117
$892.68K
—
Christopher Volker
Chief Financial Officer
$105.00K (1)
—
+$105.00K
75,000
$150.75K
—
David A Rosa
CEO & President
$50.00K (1)
—
+$50.00K
1,080,132
$2.17M
—
Amer Samad
Director
$501.72 (1)
—
+$501.72
15,728
$31.61K
−99.6%
Mayo Foundation For Medical Education & Research entity
10% owner
—
—
—
572,846
$1.15M
−33.4%
Thomas Bachinski
Chief Development Officer
—
—
—
215,453
$433.06K
—
Paul Buckman
Director
—
—
—
178,733
$359.25K
—
Jeffrey S Mathiesen
Director
—
—
—
156,343
$314.25K
—
Steve Mertens
Chief Technology Officer
—
—
—
152,141
$305.80K
—
Edward Andrle
Director
—
—
—
133,932
$269.20K
—
Jason Richard Mills
Director
—
—
—
49,687
$99.87K
—
Suraj Kalia
Director
—
—
—
14,006
$28.15K
—

No percentages here. This company's share count has moved by a factor of 5.8 over the window, from 8,619,876 to 50,413,148 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.